{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:13:39Z","timestamp":1788178419598,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ejpb.2026.115215","type":"journal-article","created":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T14:58:07Z","timestamp":1786805887000},"page":"115215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A hybrid MVDA-neural network model with auxiliary learning for pharmaceutical quality by design under small-sample constraints"],"prefix":"10.1016","volume":"227","author":[{"given":"Dongjun","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjae","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4017-3312","authenticated-orcid":false,"given":"Seung Eel","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-6085-4669","authenticated-orcid":false,"given":"Eun-Ji","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Jae","family":"Chun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Jin","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0200-2368","authenticated-orcid":false,"given":"Taeyong","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejpb.2026.115215_b0005","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s11095-007-9511-1","article-title":"Pharmaceutical quality by design: product and process development, understanding, and control","volume":"25","author":"Yu","year":"2008","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ejpb.2026.115215_b0010","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1208\/s12248-014-9598-3","article-title":"Understanding pharmaceutical quality by design","volume":"16","author":"Yu","year":"2014","journal-title":"AAPS J."},{"key":"10.1016\/j.ejpb.2026.115215_b0015","unstructured":"International Council for Harmonisation, ICH harmonised tripartite guideline Q8(R2): pharmaceutical development, ICH, Geneva, 2009."},{"key":"10.1016\/j.ejpb.2026.115215_b0020","first-page":"10","article-title":"The concept of pharmaceutical quality","volume":"7","author":"Woodcock","year":"2004","journal-title":"Am. Pharm. Rev."},{"key":"10.1016\/j.ejpb.2026.115215_b0025","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1080\/03639045.2017.1291672","article-title":"Design of experiments (DoE) in pharmaceutical development","volume":"43","author":"Politis","year":"2017","journal-title":"Drug Dev. Ind. Pharm."},{"key":"10.1016\/j.ejpb.2026.115215_b0030","doi-asserted-by":"crossref","DOI":"10.1590\/s2175-97902018000001006","article-title":"Design of experiments (DoE) applied to pharmaceutical and analytical quality by design (QbD)","volume":"54","author":"Fukuda","year":"2018","journal-title":"Braz. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115215_b0035","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/nbt0109-26","article-title":"Quality by design for biopharmaceuticals","volume":"27","author":"Rathore","year":"2009","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.ejpb.2026.115215_b0040","doi-asserted-by":"crossref","first-page":"623","DOI":"10.3390\/pharmaceutics17050623","article-title":"Aspects and implementation of pharmaceutical quality by design from conceptual frameworks to industrial applications","volume":"17","author":"Yang","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115215_b0045","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ijpharm.2015.04.038","article-title":"Implementation of quality by design principles in the development of microsponges as drug delivery carriers: identification and optimization of critical factors using multivariate statistical analyses and design of experiments studies","volume":"489","author":"Crcarevska","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115215_b0050","doi-asserted-by":"crossref","first-page":"481","DOI":"10.31925\/farmacia.2021.3.11","article-title":"Applying the principles of quality by design (QbD) coupled with multivariate data analysis (MVDA) in establishing the impact of raw material variability for extended release tablets","volume":"69","author":"Ily\u00e9s","year":"2021","journal-title":"Farmacia"},{"key":"10.1016\/j.ejpb.2026.115215_b0055","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.ejpb.2016.05.009","article-title":"Estimation of design space for an extrusion-spheronization process using response surface methodology and artificial neural network modelling","volume":"106","author":"Sov\u00e1ny","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115215_b0060","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/jps.22734","article-title":"Reliability evaluation of nonlinear design space in pharmaceutical product development","volume":"101","author":"Hayashi","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115215_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2024.106938","article-title":"Artificial intelligence-driven pharmaceutical industry: a paradigm shift in drug discovery, formulation development, manufacturing, quality control, and post-market surveillance","volume":"203","author":"Huanbutta","year":"2024","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejpb.2026.115215_b0070","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.3390\/pharmaceutics17111451","article-title":"Building artificial neural networks for the optimization of sustained-release kinetics of metronidazole from colonic hydrophilic matrices","volume":"17","author":"Maderuelo","year":"2025","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115215_b0075","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.ejpb.2020.05.012","article-title":"Artificial neural networks applied to quality-by-design: from formulation development to clinical outcome","volume":"152","author":"Sim\u00f5es","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115215_b0080","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1002\/widm.1157","article-title":"A survey on multi-output regression, WIREs","volume":"5","author":"Borchani","year":"2015","journal-title":"Data Min. Knowl. Discov."},{"key":"10.1016\/j.ejpb.2026.115215_b0085","first-page":"953","article-title":"Artificial neural networks for small dataset analysis","volume":"7","author":"Pasini","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.ejpb.2026.115215_b0090","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.artmed.2016.12.003","article-title":"Handling limited datasets with neural networks in medical applications: a small-data approach","volume":"75","author":"Shaikhina","year":"2017","journal-title":"Artif. Intell. Med."},{"key":"10.1016\/j.ejpb.2026.115215_b0095","unstructured":"L. Liebel, M. K\u00f6rner, Auxiliary tasks in multi-task learning, arXiv preprint arXiv:1805.06334, 2018. https:\/\/arxiv.org\/abs\/1805.06334."},{"key":"10.1016\/j.ejpb.2026.115215_b0100","unstructured":"S. Ruder, An overview of multi-task learning in deep neural networks, arXiv preprint arXiv:1706.05098, 2017. https:\/\/arxiv.org\/abs\/1706.05098."},{"key":"10.1016\/j.ejpb.2026.115215_b0105","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.neunet.2009.06.042","article-title":"A new learning paradigm: learning using privileged information","volume":"22","author":"Vapnik","year":"2009","journal-title":"Neural Netw."},{"key":"10.1016\/j.ejpb.2026.115215_b0110","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0925-2312(01)00702-0","article-title":"Time series forecasting using a hybrid ARIMA and neural network model","volume":"50","author":"Zhang","year":"2003","journal-title":"Neurocomputing"},{"key":"10.1016\/j.ejpb.2026.115215_b0115","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3390\/ma14081883","article-title":"Hybrid modelling by machine learning corrections of analytical model predictions towards high-fidelity simulation solutions","volume":"14","author":"Bock","year":"2021","journal-title":"Materials"},{"key":"10.1016\/j.ejpb.2026.115215_b0120","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejpb.2018.10.017","article-title":"Solid lipid nanoparticles and nanostructured lipid carriers: a review emphasizing on particle structure and drug release","volume":"133","author":"Gordillo-Galeano","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ejpb.2026.115215_b0125","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1208\/s12249-012-9844-x","volume":"13","author":"Fahmy","year":"2012","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.ejpb.2026.115215_b0130","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ijpharm.2019.01.022","article-title":"A review on 5-aminosalicylic acid colon-targeted oral drug delivery systems","volume":"558","author":"Sardo","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115215_b0135","series-title":"Design and Analysis of Experiments","author":"Montgomery","year":"2017"},{"key":"10.1016\/j.ejpb.2026.115215_b0140","unstructured":"Minitab LLC, Perform stepwise regression for Fit Regression Model and Linear Regression, Minitab Support, 2025. https:\/\/support.minitab.com\/en-us\/minitab\/help-and-how-to\/statistical-modeling\/regression\/how-to\/fit-regression-model\/perform-the-analysis\/perform-stepwise-regression\/ [accessed 26 August 2025]."},{"key":"10.1016\/j.ejpb.2026.115215_b0145","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1037\/a0021764","article-title":"Accuracy in parameter estimation for targeted effects in structural equation modeling: sample size planning for narrow confidence intervals","volume":"16","author":"Lai","year":"2011","journal-title":"Psychol. Methods"},{"key":"10.1016\/j.ejpb.2026.115215_b0150","doi-asserted-by":"crossref","DOI":"10.1016\/j.chemolab.2020.104002","article-title":"Quality by design: comparison of design space construction methods in the case of design of experiments","volume":"200","author":"Manzon","year":"2020","journal-title":"Chemometr. Intell. Lab. Syst."},{"key":"10.1016\/j.ejpb.2026.115215_b0155","first-page":"249","article-title":"Understanding the difficulty of training deep feedforward neural networks","volume":"9","author":"Glorot","year":"2010","journal-title":"Proc. Mach. Learn. Res."},{"key":"10.1016\/j.ejpb.2026.115215_b0160","unstructured":"D.P. Kingma, J. Ba, Adam: a method for stochastic optimization, arXiv preprint arXiv:1412.6980, 2014. https:\/\/arxiv.org\/abs\/1412.6980."},{"key":"10.1016\/j.ejpb.2026.115215_b0165","doi-asserted-by":"crossref","unstructured":"T. Akiba, S. Sano, T. Yanase, T. Ohta, M. Koyama, Optuna: a next-generation hyperparameter optimization framework, in: Proc. 25th ACM SIGKDD Int. Conf. Knowl. Discov. Data Min., 2019, pp. 2623\u20132631, doi: 10.1145\/3292500.3330701.","DOI":"10.1145\/3292500.3330701"},{"key":"10.1016\/j.ejpb.2026.115215_b0170","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/qre.3025","article-title":"Design of Experiments and machine learning for product innovation: a systematic literature review","volume":"38","author":"Arboretti","year":"2022","journal-title":"Qual. Reliab. Eng. Int."},{"key":"10.1016\/j.ejpb.2026.115215_b0175","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3390\/pharmaceutics14010183","article-title":"State-of-the-art review of artificial neural networks to predict, characterize and optimize pharmaceutical formulation","volume":"14","author":"Wang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ejpb.2026.115215_b0180","doi-asserted-by":"crossref","first-page":"26348","DOI":"10.52202\/075280-1146","article-title":"High dimensional, tabular deep learning with an auxiliary knowledge graph","volume":"36","author":"Ruiz","year":"2023","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"10.1016\/j.ejpb.2026.115215_b0185","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/01621459.1937.10503522","article-title":"The use of ranks to avoid the assumption of normality implicit in the analysis of variance","volume":"32","author":"Friedman","year":"1937","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.ejpb.2026.115215_b0190","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1093\/biomet\/52.3-4.591","article-title":"An analysis of variance test for normality (complete samples)","volume":"52","author":"Shapiro","year":"1965","journal-title":"Biometrika"},{"key":"10.1016\/j.ejpb.2026.115215_b0195","first-page":"65","article-title":"A simple sequentially rejective multiple test procedure","volume":"6","author":"Holm","year":"1979","journal-title":"Scand. J. Stat."},{"key":"10.1016\/j.ejpb.2026.115215_b0200","doi-asserted-by":"crossref","first-page":"591","DOI":"10.2307\/1910133","article-title":"Tests of equality between sets of coefficients in two linear regressions","volume":"28","author":"Chow","year":"1960","journal-title":"Econometrica"},{"key":"10.1016\/j.ejpb.2026.115215_b0205","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.talanta.2014.01.034","article-title":"Experimental design and multiple response optimization. Using the Desirability Function in Analytical Methods Development","volume":"124","author":"Candioti","year":"2014","journal-title":"Talanta"},{"key":"10.1016\/j.ejpb.2026.115215_b0210","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.patcog.2011.06.019","article-title":"A unifying view on dataset shift in classification","volume":"45","author":"Moreno-Torres","year":"2012","journal-title":"Pattern Recognit."},{"key":"10.1016\/j.ejpb.2026.115215_b0215","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12247-018-9345-x","article-title":"D-optimal optimization and data-analysis comparison between a DoE software and artificial neural networks of a chitosan coating process onto PLGA nanoparticles for lung and cervical cancer treatment","volume":"14","author":"Nguyen","year":"2019","journal-title":"J. Pharm. Innov."},{"key":"10.1016\/j.ejpb.2026.115215_b0220","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijpharm.2017.05.070","article-title":"Modeling in the quality by design environment: regulatory requirements and recommendations for design space and control strategy appointment","volume":"533","author":"Djuris","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejpb.2026.115215_b0225","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1198\/sbr.2009.0037","article-title":"A Bayesian design space approach to robustness and system suitability for pharmaceutical assays and other processes","volume":"1","author":"Peterson","year":"2009","journal-title":"Stat. Biopharm. Res."},{"key":"10.1016\/j.ejpb.2026.115215_b0230","unstructured":"International Council for Harmonisation, ICH harmonised guideline Q9(R1): quality risk management, ICH, Geneva, 2023."},{"key":"10.1016\/j.ejpb.2026.115215_b0235","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1080\/10543400802278197","article-title":"A Bayesian approach to the ICH Q8 definition of design space","volume":"18","author":"Peterson","year":"2008","journal-title":"J. Biopharm. Stat."}],"container-title":["European Journal of Pharmaceutics and Biopharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939641126002365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T11:14:31Z","timestamp":1788174871000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939641126002365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":47,"alternative-id":["S0939641126002365"],"URL":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115215","relation":{},"ISSN":["0939-6411"],"issn-type":[{"value":"0939-6411","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A hybrid MVDA-neural network model with auxiliary learning for pharmaceutical quality by design under small-sample constraints","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutics and Biopharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejpb.2026.115215","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"115215"}}